Healthcare Mobility Solution Market by Device Type (Smartphones, Tablets, Wearables), Technology (Bluetooth, NFC, RFID), Deployment Mode, Application, End User - Global Forecast 2025-2032
Description
The Healthcare Mobility Solution Market was valued at USD 95.99 billion in 2024 and is projected to grow to USD 113.08 billion in 2025, with a CAGR of 18.10%, reaching USD 363.43 billion by 2032.
Setting the stage for healthcare mobility’s strategic imperative by outlining device evolution, architectural choices, clinical use cases, and governance considerations
The healthcare sector is experiencing rapid digitization driven by mobility, connectivity, and a heightened focus on patient-centric care. Mobility solutions now extend beyond simple device adoption to encompass integrated systems for asset visibility, electronic prescribing, continuous patient monitoring, and workforce optimization. These combined capabilities are reshaping workflows across clinical and operational domains, demanding new approaches to device management, interoperability, data governance, and clinical change management.
As healthcare organizations pursue efficiency and resilience, mobility technologies are becoming foundational to care delivery. Cloud deployments and edge-capable on-premises systems both play important roles in meeting performance, security, and compliance requirements. Meanwhile, devices from smartphones to wearables are evolving into clinical endpoints, creating new opportunities for remote monitoring and chronic disease management. This introduction frames the strategic imperative: leaders must understand technical architectures, clinical use cases, and regulatory dynamics to prioritize investments that translate mobility into measurable improvements in care delivery and operational efficiency.
Exploring the converging technological, regulatory, and workforce dynamics that are accelerating enterprise adoption of mobility solutions across clinical and operational domains
The mobility landscape in healthcare is undergoing transformative shifts that redefine how care is delivered and how operations are managed. Improvements in wireless protocols and miniaturized sensors have expanded the practical scope of remote patient monitoring and asset tracking, enabling continuous data streams that support both clinical decision-making and back-end logistics. Simultaneously, the maturation of cloud-native services and private cloud options is creating new models for how institutions balance scalability, latency, and data residency concerns. These technological drivers interact with workforce dynamics, as staff increasingly expect consumer-grade device experiences that integrate seamlessly with clinical systems.
Regulatory focus and cybersecurity pressures are also reshaping product roadmaps and procurement criteria. Providers and vendors are investing in encryption, identity management, and secure device lifecycle practices to mitigate risk. Interoperability initiatives are gaining traction, fostering tighter integration between mobility platforms and electronic health records, medical device data systems, and supply chain platforms. Together, these shifts are catalyzing a migration from pilot deployments to enterprise-grade rollouts, with an emphasis on measurable outcomes such as reduced asset search times, improved medication safety through e-prescribing controls, and enhanced patient engagement through real-time monitoring.
Analyzing how 2025 United States tariff measures reshaped supplier selection, sourcing strategies, and device lifecycle planning for healthcare mobility deployments
The imposition of tariffs and trade measures by the United States in 2025 has introduced additional variables into procurement strategies for healthcare mobility solutions and associated hardware. Tariff changes have increased the importance of supply chain resilience and component-level sourcing decisions, prompting healthcare organizations and vendors to reassess supplier diversification, inventory policies, and total landed cost considerations. In practice, procurement teams are balancing near-term cost pressures with the operational need for uninterrupted device and accessory supply, particularly for critical items such as wearable sensors, RFID tags, and enterprise mobile devices.
Consequently, organizations are prioritizing strategies that reduce exposure to cross-border tariff volatility. These strategies include qualifying alternative suppliers in different trade regions, increasing regional assembly or final-stage configuration, and negotiating longer-term contracts with transparent tariff pass-through terms. In parallel, the tariff environment has accelerated conversations about local manufacturing and third-party logistics partnerships to shorten lead times and reduce cumulative duties. From a product perspective, vendors are adjusting BOMs and considering modular designs to enable substitution of components sourced from lower-tariff jurisdictions without compromising clinical functionality or regulatory compliance.
As a result, the tariff context has also influenced the cadence of technology refresh programs and device lifecycle planning. IT and clinical engineering teams are increasingly incorporating tariff scenarios into capital planning, recognizing that procurement timing and contract terms can materially affect acquisition cost, deployment speed, and the feasibility of large-scale rollouts. Together, these actions reflect a broader shift: organizations are treating trade policy as an operational variable rather than an externality, integrating policy risk into vendor selection, sourcing strategies, and total cost of ownership analyses.
Deep segmentation analysis explaining how deployment modes, device types, application domains, user settings, and enabling technologies guide adoption and integration choices
Segmentation insights reveal how deployment mode, device type, application areas, end-user settings, and enabling technologies collectively shape adoption pathways and value realization. When considering deployment mode, organizations weigh the flexibility and scalability of cloud based solutions against the latency, control, and compliance advantages of on premises systems; within cloud based offerings, private cloud options appeal to institutions prioritizing data residency and customized security controls, while public cloud variants drive rapid feature release cycles and broader service integrations. Device type considerations influence clinical workflows and integration work required; smartphones offer a familiar user interface and broad app ecosystems, tablets provide enhanced display and input capabilities for point-of-care tasks, and wearables enable continuous physiological monitoring and patient engagement outside the clinical setting.
Application-level segmentation further clarifies use-case priorities. Asset tracking spans both passive RFID tracking for inventory reconciliation and real-time location tracking for transient asset retrieval, enabling operations teams to reduce downtime and improve equipment utilization. E-prescribing functionality must address controlled substance management distinctly from non-controlled prescribing workflows, embedding safeguards and audit trails appropriate to each context. Patient monitoring encompasses glucose monitoring, remote cardiac monitoring, and vital signs monitoring, each with unique data cadence, integration, and clinical escalation requirements. Workforce management solutions focus on scheduling and time tracking, helping administrators balance staffing levels with patient demand while improving workforce satisfaction through transparent rostering. End-user segmentation highlights the different operational tempos and clinical expectations across clinics, home healthcare providers, and hospitals, influencing solution design, support models, and training approaches. Finally, technology choices such as Bluetooth, NFC, and RFID affect power consumption, range, interoperability, and implementation complexity, informing decisions from hardware selection to system architecture and maintenance planning.
Comparative regional perspectives on adoption drivers, regulatory nuances, and supply chain realities influencing healthcare mobility strategies across global markets
Regional dynamics materially influence implementation strategies and vendor ecosystems, with distinct patterns emerging across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, healthcare organizations often prioritize rapid innovation cycles and integrated cloud services, while also managing complex payer and regulatory landscapes that affect procurement timelines and compliance requirements. Conversely, Europe, Middle East & Africa combines a mix of stringent data protection regimes, heterogeneous healthcare delivery models, and growing interest in regional manufacturing and cybersecurity standards, which together shape how deployments are scoped and which vendors achieve traction.
Asia-Pacific presents a diverse set of drivers: some markets emphasize cost-effective scaling and local supply chain integration, while others lead in mobile-first patient engagement and widespread adoption of consumer wearables as clinical adjuncts. Across all regions, differences in reimbursement models, clinical workforce availability, and digital maturity influence prioritization of asset tracking, e-prescribing controls, patient monitoring, and workforce management. These regional distinctions affect vendor go-to-market strategies, partnership models, and the structure of support and professional services, so stakeholders must account for local regulatory compliance, language localization, and service-level expectations when planning cross-border or multi-region rollouts.
How company strategies focused on interoperability, security, professional services, and outcome-driven evidence distinguish market leaders and influence procurement decisions
Company-level dynamics revolve around innovation in device interoperability, platform extensibility, and enterprise-grade security. Leading vendors are differentiating through deep integrations with electronic health records and clinical workflows, scalable cloud and hybrid deployment options, and comprehensive device management capabilities that span provisioning, monitoring, patching, and decommissioning. Strategic partnerships and certifications that demonstrate compliance with clinical and cybersecurity standards are increasingly table stakes, and organizations evaluate vendors based on their ability to deliver predictable professional services, training, and long-term support arrangements.
Moreover, companies with flexible commercial models and modular architectures are better positioned to respond to heterogeneous end-user needs, enabling phased rollouts and targeted pilots that reduce operational disruption. Investment in platform analytics and decision-support tools enhances the value proposition by converting raw device and sensor data into actionable clinical and operational intelligence. Finally, the competitive landscape rewards vendors that can demonstrate outcomes through documented case studies, interoperability certifications, and third-party validations that reassure procurement and clinical leaders about reliability, safety, and return on effort.
Practical and prioritized recommendations for healthcare leaders to integrate mobility solutions through governance, integration strategies, workforce enablement, and supply chain resilience
Leaders seeking to extract measurable value from mobility initiatives should prioritize integration, governance, and workforce readiness in equal measure. Begin by defining clinical and operational outcomes that mobility must enable, then map those outcomes to specific use cases such as reducing time-to-deliver medications through e-prescribing controls or minimizing equipment search time via real-time location tracking. Next, select platforms that enable phased implementation, support both cloud and on-premises topology choices, and provide robust APIs for EHR and middleware integration so that data flows into existing decision-support and analytics frameworks.
Governance is essential: establish cross-functional steering that includes clinical leaders, IT, security, procurement, and frontline staff. This governance body should set data access policies, device lifecycle procedures, and incident response plans. Invest in staff training and change management to ensure clinical workflows adapt to new device-driven processes, emphasizing usability and clinician efficiency to drive adoption. From a sourcing perspective, diversify suppliers to mitigate trade and supply chain risks, include tariff sensitivity in procurement scenarios, and demand clear SLAs and support tiers. Finally, measure progress through operational KPIs and clinical quality indicators, iterating on deployments based on performance data and frontline feedback to scale successful pilots into enterprise programs.
A rigorous mixed-methods research approach blending primary stakeholder interviews, secondary technical validation, and cross-case synthesis to ensure robust and actionable insights
The research methodology combines qualitative and quantitative approaches to construct a comprehensive view of healthcare mobility adoption, architectures, and operational impacts. Primary inputs include structured interviews with clinical leaders, IT and procurement executives, clinical engineering teams, and vendor product and regulatory specialists to capture real-world deployment experiences, pain points, and success factors. Secondary inputs incorporate vendor documentation, technical whitepapers, and publicly available regulatory and standards guidance to validate product capabilities, interoperability approaches, and security practices.
Analytical techniques include cross-case synthesis to identify recurring implementation patterns and divergence drivers, as well as technology mapping to align device types and communication protocols with clinical and operational requirements. Scenario analysis is applied to assess the implications of supply chain disruptions and tariff changes on sourcing strategies. Throughout the process, findings are triangulated to ensure robustness: primary insights inform hypotheses that are tested against secondary sources, and tensions between stakeholder perspectives are surfaced and reconciled through targeted follow-up interviews. This mixed-methods approach yields pragmatic, evidence-based insights that are grounded in operational realities and validated by practitioners.
Concluding perspective on why integrated mobility strategies, interoperability, and resilient sourcing will determine which organizations achieve sustained operational and clinical gains
The combined shifts in technology, regulatory expectations, and supply chain dynamics make healthcare mobility a strategic imperative rather than a pilot-phase curiosity. Mobility solutions unlock tangible operational efficiencies and clinical capabilities when they are integrated thoughtfully into care pathways, supported by disciplined governance, and deployed with attention to interoperability and security. As devices become clinical endpoints and data flows increase in volume and criticality, organizations must treat mobility architectures as integral to broader digital transformation programs rather than isolated point solutions.
In the coming phase of adoption, the winners will be the organizations and vendors that demonstrate an ability to align technology choices with clinical workflows, manage supply chain and tariff risk, and deliver measurable outcomes through disciplined change management. By prioritizing interoperability, user-centered design, and resilient sourcing strategies, healthcare leaders can translate mobility investments into sustained improvements in patient care, operational agility, and workforce efficiency.
Note: PDF & Excel + Online Access - 1 Year
Setting the stage for healthcare mobility’s strategic imperative by outlining device evolution, architectural choices, clinical use cases, and governance considerations
The healthcare sector is experiencing rapid digitization driven by mobility, connectivity, and a heightened focus on patient-centric care. Mobility solutions now extend beyond simple device adoption to encompass integrated systems for asset visibility, electronic prescribing, continuous patient monitoring, and workforce optimization. These combined capabilities are reshaping workflows across clinical and operational domains, demanding new approaches to device management, interoperability, data governance, and clinical change management.
As healthcare organizations pursue efficiency and resilience, mobility technologies are becoming foundational to care delivery. Cloud deployments and edge-capable on-premises systems both play important roles in meeting performance, security, and compliance requirements. Meanwhile, devices from smartphones to wearables are evolving into clinical endpoints, creating new opportunities for remote monitoring and chronic disease management. This introduction frames the strategic imperative: leaders must understand technical architectures, clinical use cases, and regulatory dynamics to prioritize investments that translate mobility into measurable improvements in care delivery and operational efficiency.
Exploring the converging technological, regulatory, and workforce dynamics that are accelerating enterprise adoption of mobility solutions across clinical and operational domains
The mobility landscape in healthcare is undergoing transformative shifts that redefine how care is delivered and how operations are managed. Improvements in wireless protocols and miniaturized sensors have expanded the practical scope of remote patient monitoring and asset tracking, enabling continuous data streams that support both clinical decision-making and back-end logistics. Simultaneously, the maturation of cloud-native services and private cloud options is creating new models for how institutions balance scalability, latency, and data residency concerns. These technological drivers interact with workforce dynamics, as staff increasingly expect consumer-grade device experiences that integrate seamlessly with clinical systems.
Regulatory focus and cybersecurity pressures are also reshaping product roadmaps and procurement criteria. Providers and vendors are investing in encryption, identity management, and secure device lifecycle practices to mitigate risk. Interoperability initiatives are gaining traction, fostering tighter integration between mobility platforms and electronic health records, medical device data systems, and supply chain platforms. Together, these shifts are catalyzing a migration from pilot deployments to enterprise-grade rollouts, with an emphasis on measurable outcomes such as reduced asset search times, improved medication safety through e-prescribing controls, and enhanced patient engagement through real-time monitoring.
Analyzing how 2025 United States tariff measures reshaped supplier selection, sourcing strategies, and device lifecycle planning for healthcare mobility deployments
The imposition of tariffs and trade measures by the United States in 2025 has introduced additional variables into procurement strategies for healthcare mobility solutions and associated hardware. Tariff changes have increased the importance of supply chain resilience and component-level sourcing decisions, prompting healthcare organizations and vendors to reassess supplier diversification, inventory policies, and total landed cost considerations. In practice, procurement teams are balancing near-term cost pressures with the operational need for uninterrupted device and accessory supply, particularly for critical items such as wearable sensors, RFID tags, and enterprise mobile devices.
Consequently, organizations are prioritizing strategies that reduce exposure to cross-border tariff volatility. These strategies include qualifying alternative suppliers in different trade regions, increasing regional assembly or final-stage configuration, and negotiating longer-term contracts with transparent tariff pass-through terms. In parallel, the tariff environment has accelerated conversations about local manufacturing and third-party logistics partnerships to shorten lead times and reduce cumulative duties. From a product perspective, vendors are adjusting BOMs and considering modular designs to enable substitution of components sourced from lower-tariff jurisdictions without compromising clinical functionality or regulatory compliance.
As a result, the tariff context has also influenced the cadence of technology refresh programs and device lifecycle planning. IT and clinical engineering teams are increasingly incorporating tariff scenarios into capital planning, recognizing that procurement timing and contract terms can materially affect acquisition cost, deployment speed, and the feasibility of large-scale rollouts. Together, these actions reflect a broader shift: organizations are treating trade policy as an operational variable rather than an externality, integrating policy risk into vendor selection, sourcing strategies, and total cost of ownership analyses.
Deep segmentation analysis explaining how deployment modes, device types, application domains, user settings, and enabling technologies guide adoption and integration choices
Segmentation insights reveal how deployment mode, device type, application areas, end-user settings, and enabling technologies collectively shape adoption pathways and value realization. When considering deployment mode, organizations weigh the flexibility and scalability of cloud based solutions against the latency, control, and compliance advantages of on premises systems; within cloud based offerings, private cloud options appeal to institutions prioritizing data residency and customized security controls, while public cloud variants drive rapid feature release cycles and broader service integrations. Device type considerations influence clinical workflows and integration work required; smartphones offer a familiar user interface and broad app ecosystems, tablets provide enhanced display and input capabilities for point-of-care tasks, and wearables enable continuous physiological monitoring and patient engagement outside the clinical setting.
Application-level segmentation further clarifies use-case priorities. Asset tracking spans both passive RFID tracking for inventory reconciliation and real-time location tracking for transient asset retrieval, enabling operations teams to reduce downtime and improve equipment utilization. E-prescribing functionality must address controlled substance management distinctly from non-controlled prescribing workflows, embedding safeguards and audit trails appropriate to each context. Patient monitoring encompasses glucose monitoring, remote cardiac monitoring, and vital signs monitoring, each with unique data cadence, integration, and clinical escalation requirements. Workforce management solutions focus on scheduling and time tracking, helping administrators balance staffing levels with patient demand while improving workforce satisfaction through transparent rostering. End-user segmentation highlights the different operational tempos and clinical expectations across clinics, home healthcare providers, and hospitals, influencing solution design, support models, and training approaches. Finally, technology choices such as Bluetooth, NFC, and RFID affect power consumption, range, interoperability, and implementation complexity, informing decisions from hardware selection to system architecture and maintenance planning.
Comparative regional perspectives on adoption drivers, regulatory nuances, and supply chain realities influencing healthcare mobility strategies across global markets
Regional dynamics materially influence implementation strategies and vendor ecosystems, with distinct patterns emerging across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, healthcare organizations often prioritize rapid innovation cycles and integrated cloud services, while also managing complex payer and regulatory landscapes that affect procurement timelines and compliance requirements. Conversely, Europe, Middle East & Africa combines a mix of stringent data protection regimes, heterogeneous healthcare delivery models, and growing interest in regional manufacturing and cybersecurity standards, which together shape how deployments are scoped and which vendors achieve traction.
Asia-Pacific presents a diverse set of drivers: some markets emphasize cost-effective scaling and local supply chain integration, while others lead in mobile-first patient engagement and widespread adoption of consumer wearables as clinical adjuncts. Across all regions, differences in reimbursement models, clinical workforce availability, and digital maturity influence prioritization of asset tracking, e-prescribing controls, patient monitoring, and workforce management. These regional distinctions affect vendor go-to-market strategies, partnership models, and the structure of support and professional services, so stakeholders must account for local regulatory compliance, language localization, and service-level expectations when planning cross-border or multi-region rollouts.
How company strategies focused on interoperability, security, professional services, and outcome-driven evidence distinguish market leaders and influence procurement decisions
Company-level dynamics revolve around innovation in device interoperability, platform extensibility, and enterprise-grade security. Leading vendors are differentiating through deep integrations with electronic health records and clinical workflows, scalable cloud and hybrid deployment options, and comprehensive device management capabilities that span provisioning, monitoring, patching, and decommissioning. Strategic partnerships and certifications that demonstrate compliance with clinical and cybersecurity standards are increasingly table stakes, and organizations evaluate vendors based on their ability to deliver predictable professional services, training, and long-term support arrangements.
Moreover, companies with flexible commercial models and modular architectures are better positioned to respond to heterogeneous end-user needs, enabling phased rollouts and targeted pilots that reduce operational disruption. Investment in platform analytics and decision-support tools enhances the value proposition by converting raw device and sensor data into actionable clinical and operational intelligence. Finally, the competitive landscape rewards vendors that can demonstrate outcomes through documented case studies, interoperability certifications, and third-party validations that reassure procurement and clinical leaders about reliability, safety, and return on effort.
Practical and prioritized recommendations for healthcare leaders to integrate mobility solutions through governance, integration strategies, workforce enablement, and supply chain resilience
Leaders seeking to extract measurable value from mobility initiatives should prioritize integration, governance, and workforce readiness in equal measure. Begin by defining clinical and operational outcomes that mobility must enable, then map those outcomes to specific use cases such as reducing time-to-deliver medications through e-prescribing controls or minimizing equipment search time via real-time location tracking. Next, select platforms that enable phased implementation, support both cloud and on-premises topology choices, and provide robust APIs for EHR and middleware integration so that data flows into existing decision-support and analytics frameworks.
Governance is essential: establish cross-functional steering that includes clinical leaders, IT, security, procurement, and frontline staff. This governance body should set data access policies, device lifecycle procedures, and incident response plans. Invest in staff training and change management to ensure clinical workflows adapt to new device-driven processes, emphasizing usability and clinician efficiency to drive adoption. From a sourcing perspective, diversify suppliers to mitigate trade and supply chain risks, include tariff sensitivity in procurement scenarios, and demand clear SLAs and support tiers. Finally, measure progress through operational KPIs and clinical quality indicators, iterating on deployments based on performance data and frontline feedback to scale successful pilots into enterprise programs.
A rigorous mixed-methods research approach blending primary stakeholder interviews, secondary technical validation, and cross-case synthesis to ensure robust and actionable insights
The research methodology combines qualitative and quantitative approaches to construct a comprehensive view of healthcare mobility adoption, architectures, and operational impacts. Primary inputs include structured interviews with clinical leaders, IT and procurement executives, clinical engineering teams, and vendor product and regulatory specialists to capture real-world deployment experiences, pain points, and success factors. Secondary inputs incorporate vendor documentation, technical whitepapers, and publicly available regulatory and standards guidance to validate product capabilities, interoperability approaches, and security practices.
Analytical techniques include cross-case synthesis to identify recurring implementation patterns and divergence drivers, as well as technology mapping to align device types and communication protocols with clinical and operational requirements. Scenario analysis is applied to assess the implications of supply chain disruptions and tariff changes on sourcing strategies. Throughout the process, findings are triangulated to ensure robustness: primary insights inform hypotheses that are tested against secondary sources, and tensions between stakeholder perspectives are surfaced and reconciled through targeted follow-up interviews. This mixed-methods approach yields pragmatic, evidence-based insights that are grounded in operational realities and validated by practitioners.
Concluding perspective on why integrated mobility strategies, interoperability, and resilient sourcing will determine which organizations achieve sustained operational and clinical gains
The combined shifts in technology, regulatory expectations, and supply chain dynamics make healthcare mobility a strategic imperative rather than a pilot-phase curiosity. Mobility solutions unlock tangible operational efficiencies and clinical capabilities when they are integrated thoughtfully into care pathways, supported by disciplined governance, and deployed with attention to interoperability and security. As devices become clinical endpoints and data flows increase in volume and criticality, organizations must treat mobility architectures as integral to broader digital transformation programs rather than isolated point solutions.
In the coming phase of adoption, the winners will be the organizations and vendors that demonstrate an ability to align technology choices with clinical workflows, manage supply chain and tariff risk, and deliver measurable outcomes through disciplined change management. By prioritizing interoperability, user-centered design, and resilient sourcing strategies, healthcare leaders can translate mobility investments into sustained improvements in patient care, operational agility, and workforce efficiency.
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
185 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Increasing integration of wearable sensors with EHR systems for remote patient monitoring in real time
- 5.2. Adoption of AI-powered mobile diagnostic tools to accelerate point-of-care decision making in hospitals
- 5.3. Implementation of 5G-enabled telehealth platforms supporting high-resolution imaging and low-latency consultations
- 5.4. Growing use of secure mobile apps with blockchain-based authentication to ensure patient data privacy compliance
- 5.5. Expansion of mobile rehabilitation apps incorporating gamification and motion tracking for improved therapy adherence
- 5.6. Surge in cross-platform interoperability standards streamlining data exchange between devices and hospital networks
- 5.7. Utilization of predictive analytics in mHealth apps to identify high-risk patients and reduce readmission rates
- 5.8. Development of voice-enabled mobile assistants for clinicians to streamline documentation and order entry workflows
- 5.9. Integration of AR-capable mobile devices for training healthcare professionals in immersive simulated procedures
- 5.10. Emerging partnerships between mobile health startups and pharmaceutical companies for patient adherence monitoring
- 6. Cumulative Impact of United States Tariffs 2025
- 7. Cumulative Impact of Artificial Intelligence 2025
- 8. Healthcare Mobility Solution Market, by Device Type
- 8.1. Smartphones
- 8.2. Tablets
- 8.3. Wearables
- 9. Healthcare Mobility Solution Market, by Technology
- 9.1. Bluetooth
- 9.2. NFC
- 9.3. RFID
- 10. Healthcare Mobility Solution Market, by Deployment Mode
- 10.1. Cloud Based
- 10.1.1. Private Cloud
- 10.1.2. Public Cloud
- 10.2. On Premises
- 11. Healthcare Mobility Solution Market, by Application
- 11.1. Asset Tracking
- 11.1.1. Passive RFID Tracking
- 11.1.2. Real-Time Location Tracking
- 11.2. E-Prescribing
- 11.2.1. Controlled Substance Management
- 11.2.2. Non-Controlled Substance Management
- 11.3. Patient Monitoring
- 11.3.1. Glucose Monitoring
- 11.3.2. Remote Cardiac Monitoring
- 11.3.3. Vital Signs Monitoring
- 11.4. Workforce Management
- 11.4.1. Scheduling
- 11.4.2. Time Tracking
- 12. Healthcare Mobility Solution Market, by End User
- 12.1. Clinics
- 12.2. Home Healthcare
- 12.3. Hospitals
- 13. Healthcare Mobility Solution Market, by Region
- 13.1. Americas
- 13.1.1. North America
- 13.1.2. Latin America
- 13.2. Europe, Middle East & Africa
- 13.2.1. Europe
- 13.2.2. Middle East
- 13.2.3. Africa
- 13.3. Asia-Pacific
- 14. Healthcare Mobility Solution Market, by Group
- 14.1. ASEAN
- 14.2. GCC
- 14.3. European Union
- 14.4. BRICS
- 14.5. G7
- 14.6. NATO
- 15. Healthcare Mobility Solution Market, by Country
- 15.1. United States
- 15.2. Canada
- 15.3. Mexico
- 15.4. Brazil
- 15.5. United Kingdom
- 15.6. Germany
- 15.7. France
- 15.8. Russia
- 15.9. Italy
- 15.10. Spain
- 15.11. China
- 15.12. India
- 15.13. Japan
- 15.14. Australia
- 15.15. South Korea
- 16. Competitive Landscape
- 16.1. Market Share Analysis, 2024
- 16.2. FPNV Positioning Matrix, 2024
- 16.3. Competitive Analysis
- 16.3.1. AirStrip Technologies, Inc.
- 16.3.2. Apple, Inc.
- 16.3.3. AT&T Inc.
- 16.3.4. BlackBerry Limited
- 16.3.5. Broadcom, Inc.
- 16.3.6. Cisco Systems, Inc.
- 16.3.7. Cloud Software Group, Inc.
- 16.3.8. Express Scripts Holding Company
- 16.3.9. Hewlett-Packard Company
- 16.3.10. Honeywell International Inc
- 16.3.11. Infosys limited
- 16.3.12. International Business Machines Corporation
- 16.3.13. Koninklijke Philips N.V.
- 16.3.14. McKesson Corporation
- 16.3.15. Microsoft Corporation
- 16.3.16. OMRON Corporation
- 16.3.17. Oracle Corporation
- 16.3.18. SAP SE
- 16.3.19. SATO Holdings Corporation
- 16.3.20. SOTI Inc.
- 16.3.21. Verizon Communications, Inc.
- 16.3.22. Wipro Limited
- 16.3.23. Zebra Technologies Corporation
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
